MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Right now, Eli ... Lilly may be entering yet a new growth period, there's a lingering competitive threat looming in the ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...
INDIANAPOLIS, Nov. 1, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: NYSE:LLY) today announced that data from the Phase 3 trial (EMBER-3) for imlunestrant, an oral selective ...